Literature DB >> 19861350

Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential.

Thomas Unger1, Björn Dahlöf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19861350     DOI: 10.1177/1470320309347792

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


× No keyword cloud information.
  22 in total

Review 1.  Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.

Authors:  Masatsugu Horiuchi; Masaki Mogi
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

2.  Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure.

Authors:  Juan Gao; Irving H Zucker; Lie Gao
Journal:  Am J Hypertens       Date:  2014-03-31       Impact factor: 2.689

3.  Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic α-cell-dependent mechanism.

Authors:  Martin Mildner; Helge Müller-Fielitz; Ines Stölting; Olaf Jöhren; Muscha Steckelings; Walter Raasch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-31       Impact factor: 3.000

Review 4.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

Review 5.  Novel therapeutic targets for the treatment of heart failure.

Authors:  Juan Tamargo; José López-Sendón
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

Review 6.  Drug discovery in renin-angiotensin system intervention: past and future.

Authors:  Bryan Williams
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-04-27

7.  Role of the renin angiotensin system in diabetic nephropathy.

Authors:  Tanuj Chawla; Deepika Sharma; Archana Singh
Journal:  World J Diabetes       Date:  2010-11-15

Review 8.  The renin-angiotensin system and cancer: old dog, new tricks.

Authors:  Amee J George; Walter G Thomas; Ross D Hannan
Journal:  Nat Rev Cancer       Date:  2010-10-22       Impact factor: 60.716

9.  Angiotensin type 2 receptor in pancreatic islets of adult rats: a novel insulinotropic mediator.

Authors:  Chunhong Shao; Irving H Zucker; Lie Gao
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-01       Impact factor: 4.310

10.  Activation of angiotensin type 2 receptors partially ameliorates streptozotocin-induced diabetes in male rats by islet protection.

Authors:  Chunhong Shao; Li Yu; Lie Gao
Journal:  Endocrinology       Date:  2013-12-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.